Net Cash Provided by (Used in) Operating Activities |
263M |
USD |
+3.95% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
117M |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-220M |
USD |
+44.6% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
2K |
shares |
0% |
Q4 2024 |
FY 2024 |
Common Stock, Shares, Issued |
1 |
shares |
0% |
Q4 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
150M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
600M |
USD |
-17.7% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Valuation Allowance |
51M |
USD |
+30.8% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
218M |
USD |
+1.87% |
Q4 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
7M |
USD |
-12.5% |
Q1 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
344M |
USD |
-45.6% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
134M |
USD |
+12.6% |
Q4 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
185M |
USD |
+3.93% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
114M |
USD |
-20.8% |
Q4 2024 |
FY 2024 |
Interest Expense |
1.18B |
USD |
+47.6% |
Q2 2024 |
Q2 2024 |